Basal cytokines profile in metastatic renal cell carcinoma patients treated with subcutaneous IL-2-based therapy compared with that of healthy donors.

Basal cytokines profile in metastatic renal cell carcinoma patients treated with subcutaneous IL-2-based therapy compared with that of healthy donors.

Item
http://www.wikidata.org/entity/Q36316017
Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosisC-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic ReviewCirculating biomarkers in advanced renal cell carcinoma: clinical applicationsImpairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional studyHigh immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccinationCirculating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma.Cross-talk between tumor and myeloid cells: how to tip the balance in favor of antitumor immunity.Adoptive T-cell therapy: a need for standard immune monitoring.Clinical and immunomodulatory effects of bevacizumab and low-dose interleukin-2 in patients with metastatic renal cell carcinoma: results from a phase II trial.Immune responses to cancer: are they potential biomarkers of prognosis?Angiogenic, inflammatory and immunologic markers in predicting response to sunitinib in metastatic renal cell carcinoma.Deregulated systemic IL-10/IL-12 balance in advanced and poor prognosis paediatric soft tissue sarcomas.Impact of baseline visceral fat accumulation on prognosis in patients with metastatic renal cell carcinoma treated with systemic therapy.Cytokine Measurements for Diagnosing and Characterizing Leukemoid Reactions and Immunohistochemical Validation of a Granulocyte Colony-Stimulating Factor and CXCL8-Producing Renal Cell Carcinoma
P2860

Basal cytokines profile in metastatic renal cell carcinoma patients treated with subcutaneous IL-2-based therapy compared with that of healthy donors.

Item
http://www.wikidata.org/entity/Q36316017
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Basal cytokines profile in met ...... d with that of healthy donors.
@ast
Basal cytokines profile in met ...... d with that of healthy donors.
@en
type
label
Basal cytokines profile in met ...... d with that of healthy donors.
@ast
Basal cytokines profile in met ...... d with that of healthy donors.
@en
prefLabel
Basal cytokines profile in met ...... d with that of healthy donors.
@ast
Basal cytokines profile in met ...... d with that of healthy donors.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P698
P932
P356
P1433
P1476
Basal cytokines profile in met ...... d with that of healthy donors.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P698
P932